Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human monoclonal antibody of the IgG1 kappa class against human macrophage colony-stimulating factor

EU orphan designation number: EU/3/14/1350   
Active ingredient: Recombinant human monoclonal antibody of the IgG1 kappa class against human macrophage colony-stimulating factor
Indication: Treatment of tenosynovial giant cell tumour, localised and diffused type
Sponsor: Novartis Europharm Limited
Frimley Business Park, Camberley GU16 7SR, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/10/2014 Orphan designation EMA/OD/107/14 (2014)7649 of 15/10/2014